Abivax ADR (NASDAQ:ABVX) shares, rose in value on Friday, June 20, with the stock price down by -1.32% to the previous day’s close as strong demand from buyers drove the stock to $5.97.
Actively observing the price movement in the last trading, the stock closed the session at $6.05, falling within a range of $5.8825 and $6.18. The value of beta (5-year monthly) was 1.509. Referring to stock’s 52-week performance, its high was $14.22, and the low was $4.77. On the whole, ABVX has fluctuated by 2.93% over the past month.
With the market capitalization of Abivax ADR currently standing at about $378.80 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-24.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 2.97M, with a low estimate of 1.16M and a high estimate of 1.22M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.19M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ABVX’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ABVX currently trading nearly -11.89% and -9.17% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.44, while the 7-day volatility ratio is showing 4.55% which for the 30-day chart, stands at 6.25%. Furthermore, Abivax ADR (ABVX)’s beta value is 0.01, and its average true range (ATR) is 0.51.
A comparison of Abivax ADR (ABVX) with its peers suggests the former has fared considerably weaker in the market. ABVX showed an intraday change of -1.32% in last session, and over the past year, it shrunk by -55.94%%.
Data on historical trading for Abivax ADR (NASDAQ:ABVX) indicates that the trading volumes over the past 10 days have averaged 0.24 and over the past 3 months, they’ve averaged 186.53K. According to company’s latest data on outstanding shares, there are 63.35 million shares outstanding.
Nearly 12.35% of Abivax ADR’s shares belong to company insiders and institutional investors own 39.29% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.26 million shares as on 2025-05-30, resulting in a short ratio of 6.8. According to the data, the short interest in Abivax ADR (ABVX) stood at 245.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 1.37 million. The stock has fallen by -18.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ABVX stock heading into the next quarter.
